CTOs on the Move


 
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and chronic pain. We leverage Nektar`s proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.nektar.com
  • 455 Mission Bay Boulevard South
    San Francisco, CA USA 94158
  • Phone: 415.482.5300

Executives

Name Title Contact Details
John Cummings
Senior Vice President of Information Technology Profile

Funding

Nektar raised $20M on 06/02/2016

Similar Companies

Cardioxyl Pharmaceuticals

Cardioxyl Pharmaceuticals is a Chapel Hill, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Talia Technology (Marco Ophthalmic)

Talia Technology (Marco Ophthalmic Inc.) is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Breckenridge Pharmaceutical

Breckenridge Pharmaceutical Inc. is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pacific Biomarkers

Pacific Biomarkers is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cingulate

The Investor Relations website contains information about Cingulate Incs business for stockholders, potential investors, and financial analysts.